Browse > Article
http://dx.doi.org/10.14400/JDC.2019.17.10.349

Obesity as associated factors for Insulin, Fasting blood sugar, and Hemoglobin A1c in Korean adults  

Park, Jaewon (Department of Nursing, Hannam University)
Lee, Heashoon (Department of Nursing, Hannam University)
Publication Information
Journal of Digital Convergence / v.17, no.10, 2019 , pp. 349-357 More about this Journal
Abstract
The purpose of this study was to investigate the effects of body mass index(BMI) on insulin. fasting blood sugar(FBS), and hemoglobin A1c(HbA1c). This study analyzed the data of 2015, The Sixth KNHANES, and it was included to 4554 subject over 20 years old. Data were analyzed using descriptive statistics, t-test, ANOVA, Pearson correlation coefficient and stepwise multiple regression analysis(SPSS 25.0). The major findings, BMI was positively correlated with insulin(r=0.397, p<0.001), FBS(r=0.241, p<0.001), and HbA1c(r=0.237, p<0.001). Factors affecting insulin are overweight(${\beta}=.130$, t=8.193, p<0.001), obesity(${\beta}=.390$, t=24.390, p<0.001) and age. the explanatory power is 13.1% (F=53.584, p<0.001). Factors affecting FBS were overweight(${\beta}=.072$, t=4.478, p<0.001), obesity(${\beta}=.186$, t= 11.485, p<0.001), age, the explanatory power was 10.6% (F=42.351, p<0.001). Factors affecting HbA1c were overweight(${\beta}=.059$, t=3.712, p<0.001), obesity(${\beta}=.190$, t=11.895, p<0.001) age and sex, the explanatory power is 14.1% (F=58.134, p<0.001). Based on this study result, diabetes mellitus prevention and management programs should include interventions related to obesity.
Keywords
Adult; Body Mass Index; Insulin; Fasting blood sugar; Hemoglobin A1c; KNHANES;
Citations & Related Records
연도 인용수 순위
  • Reference
1 G. Assmann, J.R. Nofer & H. Schulte, (2004).Cardiovascular risk assessment in the metabolic syndrome: view from PROCAM. Endocrinology and metabolism clinics of North America, 33(2), 377-392. DOI:10.1016/j.ecl.2004.03.017   DOI
2 J. G. Salway. (2004). Metabolism at a Glance(3rd ed). Oxford: Wiley-Blackwell.
3 G. I. Shulman. (2000). Cellular mechanisms of insulin resistance. The Journal of Clinical Investigation, 106(2), 171-176. DOI: 10.1172/JCI10583   DOI
4 H. Xu, G.T.Barnes, Q. Yang, G. Tan, Yang D, C. J. Chou et al. (2003). Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. The Journal of clinical investigation, 112(12), 1821-1830. DOI: 10.1172/JCI19451   DOI
5 K. Morino, K.F. Petersen, S.Dufour, D.Befroy, J. Frattini, N. Shatzkes et al. (2005). Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2diabetic parents. The Journal of Clinical Investigation, 115(12), 3587-3593. DOI: 10.1172/JCI25151   DOI
6 D. Haslam & W. James. (2005). Obesity. Lancet, 366(9492),1197-1209. DOI:10.1016/S0140-6736(05)67483-1   DOI
7 K. E. Wellen & G. S. Hotamisligil. (2003). Obesity-induced inflammatory changes in adipose tissue. The Journal of clinical investigation, 112(12),1785-1788. DOI: 10.1172/JCI200320514.   DOI
8 World Health Organization. (2002). Reducing Risks Promoting Healthy Life. Geneva: World Health Report.
9 K. M. Flegal, J. A. Shepherd, A. C. Looker, B. I. Graubard, Lori G Borrud & C. L. Ogden et al. (2009).Comparisons of percentage body fat, body mass index, waist circumference, and waist-stature ratio in adults. The American journal of clinical nutrition, 89(2),500-508. DOI: 10.3945/ajcn.2008.26847   DOI
10 S. Wild, G. Roglic, A. Green, Sicree, R & H. King. (2004). Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 27(5),1047-1053. DOI: 10.2337/diacare.27.5.1047   DOI
11 T. Fulop, A. Larbi & N. Douziech. (2003). Insulin receptor and ageing. Pathologie-biologie, 51(10), 574-580.   DOI
12 Korea Centers for Disease Control and Prevention. (2017). The Seventh Korea National Health and Nutrition Examination Survey (KNHANES VII-2). Cheongju: Korea Centers for Disease Control and Prevention.
13 D. Hou, X. Zhao, J. Liu, F. Chen, Y. Yan, H. Cheng et al. (2016). Association of childhood and adolescents obesity with adult diabetes. Chinese journal of preventive medicine, 50(1), 23-27. DOI:10.3760/cma.j.issn.0253-9624.2016.01.005   DOI
14 M. D. Llorente & V. Urrutia. (2006). Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications. Clinical Diabetes, 24(1), 18-24. DOI:10.2337/diaclin.24.1.18   DOI
15 N. J. Kellow, G. S. Savige & H. Khalil. (2011).Predictors of poor glycaemic control during the initial five years post-diagnosis in rural adults with type 2 diabetes. The Australian journal of rural health, 19(5), 267-274. DOI:10.1111/j.1440-1584.2011.01222.   DOI
16 J. E. Gerich. (2003). Contributions of insulin-resistance and insulin secretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clinic proceedings, 78(4),447-456. DOI:10.4065/78.4.447   DOI
17 L. N. Pani, L. Korenda, J.B. Meigs, C. Driver, S. Chamany & C.S. Fox. (2008). Effect of aging on A1C levels in individuals without diabetes: Evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001-2004. Diabetes Care, 31(10), 1991-1996. DOI:10.2337/dc08-0577   DOI
18 D. B. Sacks, M. Arnold, G. L. Bakris, D. E. Bruns, A.R. Horvath & M. S. Kirkman et al. (2011). Guideline and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care, 34(6), e61-e99. DOI:10.2337/dc11-9998   DOI
19 T.A.Buchanan, A.H. Xiang, R.K. Peters, S.L. Kjos, A. Marroquin, J. Goico et al. (2002). Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes, 51(9), 2796-2803. DOI: 10.2337/diabetes.51.9.2796   DOI
20 J. P. Boyle, T. J. Thompson, E. W. Gregg, L. E. Barker & D. F. Williamson. (2010). Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Population health metrics, 8(29), 1-12. DOI:10.1186/1478-7954-8-29.   DOI
21 H. J. Yoon, Y. H. Lee & B. S. Cha. (2014). Causal Relationship of Non-alcoholic Fatty Liver Disease with Obesity and Insulin Resistance. The Journal of Korean Diabetes, 15(2), 76-81. DOI:10.4093/jkd.2014.15.2.76   DOI
22 R. Akter, A. Nessa, M. F. Husain, F. Wahed, N. Khatun, M. Yesmin. (2017). Effect of Obesity on Fasting Blood Sugar. Mymensingh medical journal, 26(1),7-11.
23 B. G. Vittal, G. Praveen & P. Deepak. (2010). A Study Of Body Mass Index In Healthy Individuals And Its Relationship With Fasting Blood Sugar. Journal of Clinical and Diagnostic Research, 4(6), 3421-3424.
24 American Diabetes Association. (2010). Standards of medical care in diabetes 2010. Diabetes Care, 33(Supplement 1), S11-S61. DOI: 10.2337/dc10-S011   DOI
25 World Health Organization Western Pacific Region. (2000).The Asia-pacific perspective: Redefining obesity and its Treatment. Australia: WHO Western Pacific Region.
26 S. I. Sherwani, H.A. Khan, A. Ekhzaimy, A.M & M. K.Sakharkar. (2016). Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients. Biomark Insights, 11, 95-104. DOI: 10.4137/BMI.S38440
27 Q. Ma, H. Liu, G. Xiang, W. Shan, & A. Xing. (2016). Association between glycated hemoglobin A1c levels with age and gender in Chinese adults with no prior diagnosis of diabetes mellitus. Biomedical Reports, 4(6), 737-740. DOI: 10.3892/br.2016.643   DOI
28 G. Bicescu. (2010). Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. Mædica, 5(1), 80-81.
29 T. Nakagami, M. Tominaga, R. Nishimura, M. Daimon, T. Oizumi, N. Yoshiike et al. (2007). The combined use of fasting plasma glucose and glycated haemoglobin A1c in a stepwise fashion to detect undiagnosed diabetes mellitus. The Tohoku journal of experimental medicine, 213(1), 25-32. DOI: 10.1620/tjem.213.25   DOI
30 M. K. Song, J. W. Bae, Y. H. Kim & S. H. Chung. (2012). Hemoglobin A1c in the Screening of Obesity Related Diseases in Children and Adolescents 2012. Annals Pediatric Endocrinology & Metabolism, 17(2),92-99. DOI: 10.6065/apem.2012.17.2.92   DOI
31 K. W. Sim, S.H. Lee & H. S. Lee. (2001). The relationship body mass index and morbidity in Korea. Journal of Korean Society for the Study of Obesity, 10(2),147-155.
32 J.K.Kim, Y.J. Kim, J.J. Fillmore, Y. Chen, I. Moore, J. Lee et al. (2001). Prevention of fat-induced insulin resistance by salicylate. The Journal of Clinical Investigation, 108(3), 437-446. DOI:10.1172/JCI11559.   DOI
33 K. F. Petersen, S. Dufour, D.Befroy, M.Lehrke, R.E.Hendler & G.I. Shulman. (2005). Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes, 54, 603-608.   DOI
34 H. J. Kim, T. Higashimori, S.Y. Park, H. Choi, J. Dong, Y. J. Kim. (2004). Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes, 53, 1060-1067.   DOI
35 C. S. Choi. (2009). PotentialPotential Therapeutic Strategies for Fat Induced Insulin Resistance. Journal of Korean Society of Endocrinology, 24(2), 65-74. DOI: 10.3803/jkes.2009.24.2.65   DOI
36 M. S. D'souza, R. Venkatesaperumal, S.N. Karkada & A.D. Amirtharaj. (2013). Determinants of Glycosylated Haemaglobin among Adults with Type 2, Diabetes Mellitus. Journal of Diabetes & Metabolism, 4(5), 265-270. DOI:10.4172/2155-6156.1000265   DOI
37 R. Weiss & S. Caprio. (2005). The metabolic consequences of childhood obesity. Best Practice & Research: Clinical Endocrinology & Metabolism, 19(3), 405-419. DOI:10.1016/j.beem.2005.04.009   DOI
38 V.A. Diaz, A.G. Mainous, R. Baker, M. Carnemolla & A. Majeed. (2007). How does ethnicity affect the association between obesity and diabetes? Diabetic medicine : a journal of the British Diabetic Association, 24(11), 1199-1204. DOI:10.1111/j.1464-5491.2007.02244.x   DOI
39 G. I. Shulman. (2000). Cellular mechanisms of insulin resistance. The Journal of clinical investigation, 106(2),171-176. DOI:10.1172/JCI10583   DOI